France· FR:66988648
PLEGRIDY 125 microgrammes, solution injectable en seringue préremplie
A peginterferon beta-1a product containing péginterféron bêta-1a, registered in France by BIOGEN NETHERLANDS (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Peginterferon beta-1a is registered in 14 of 19 countries.
Countries holding a registration under ATC L03AB13 (peginterferon beta-1a), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Peginterferon beta-1a · ATC L03AB13
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of peginterferon beta-1a costs, country by country.
Normalised to the WHO defined daily dose (8.9 mcg), the median price runs from $1.58 in Czechia to $45.18 in Switzerland — a ×29 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Peginterferon beta-1a · price per daily dose (8.9 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$45.18
- CZ Czechia$1.58
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PÉGINTERFÉRON BÊTA-1A
- Manufacturer
- BIOGEN NETHERLANDS (PAYS-BAS)
- Country
- France (FR)
- ATC code
- L03AB13
- ATC class
- Peginterferon beta-1a
- Defined daily dose
- 8.9 mcg, P
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009279493262 seringue(s) préremplie(s) en verre de 0,5 ml (voie sous-cutanée)EUR 475.1
- cip1334009302195602 seringue(s) préremplie(s) en verre de 0,5 ml (voie intramusculaire)EUR 475.1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
338 interactions on record for peginterferon beta-1a.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Peginterferon beta-1a · interactions on record
338 records
- 15 severe
- 323 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- ZidovudineJ05AF01severe
- ClotrimazoleA01AB18moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Peginterferon beta-1a in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPLEGRIDYBiogen Netherlands B.V., Badhoevedorp
- United StatesPlegridyBiogen Inc.
- United KingdomPlegridy 125micrograms/0.5ml solution for injection pre-filled pensBiogen Idec Ltd
- SpainPLEGRIDY 125 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA IMBiogen Netherlands B.V.
- FinlandPlegridyBiogen Netherlands B.V.
- BelgiumPlegridy 125 µgBiogen Netherlands
- IcelandPlegridyBiogen Netherlands B.V.
- ItalyPLEGRIDY*1 penna SC 63 mcg 0,5 ml + 1 penna 94 mcg 0,5 mlBIOGEN NETHERLANDS B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Plegridy
- Liechtenstein · Plegridy
- Norway · Plegridy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d292f4e2-e3de-4f53-86e3-c76590b24b63 GET /v1/drugs/d292f4e2-e3de-4f53-86e3-c76590b24b63?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66988648",
"date_amm": "2014-07-18",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/934",
"substance": "PÉGINTERFÉRON BÊTA-1A",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intramusculaire;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about peginterferon beta-1a.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.